nogrЭкспериментальная и клиническая гастроэнтерологияExperimental and Clinical Gastroenterology1682-8658«Global Media Technologies»10.31146/1682-8658-ecg-195-11-75-78nogr-1785Research ArticleЭКСПЕРИМЕНТАЛЬНАЯ ГАСТРОЭНТЕРОЛОГИЯEXPERIMENTAL GASTROENTEROLOGYВлияние пентагастрина и гастрина-17 на секреторную функцию желудочных железEffect of pentagastrin and gastrin-17 on the secretory function of the gastric glandshttps://orcid.org/0000-0002-8338-1122ЖураеваМ. А.ZhuraevaM. A.

Жураева Мохигуль Азимжановна, д. м. н., профессор РАЕ, доцент кафедры ВОП-1 лечебный факультет

г. Андижан, 170127, ул, Атабекова, 1

Mohigul A. Zhuraeva, MD, Professor of RAE, Associate Professor of the Department of GP-1 Medical Faculty

Andijan, 170127, Atabekov str., 1

mohigul_azimovna@mail.ruАлейникВ. А.AleynikV. A.

Алейник Владимир Алексеевич, д. м. н., профессор, профессор кафедры нормальной физиологии

г. Андижан, 170127, ул, Атабекова, 1

Vladimir A. Aleynik, MD, Professor, Professor of the Department of Normal Physiology

Andijan, 170127, Atabekov str., 1

АшуралиеваН. Д.AshuralievaN. D.

Ашуралиева Нилюфар Дильшод кизи, ассистент кафедры пропедевтики внутренних болезней лечебный факультет

г. Андижан, 170127, ул, Атабекова, 1

Nilufar D. kizi. Ashuralieva, Assistant of the Department of Propaedeutics of Internal Diseases, Faculty of medicine

Andijan, 170127, Atabekov str., 1

ХоликоваД. С.KholikovaD. S.

Холикова Дильрабо Собировна, ассистент кафедры пропедевтики внутренних болезней лечебный факультет

г. Андижан, 170127, ул, Атабекова, 1

Dilrabo S. Kholikova, Assistant of the Department of Propaedeutics of Internal Diseases, Faculty of medicine

Andijan, 170127, Atabekov str., 1

Андижанский государственный медицинский институт (АГМИ)УзбекистанAndijan State Medical Institute (ASMI)Uzbekistan2021020120220117578Copyright © Жураева М.А., Алейник В.А., Ашуралиева Н.Д., Холикова Д.С., 20222022Жураева М.А., Алейник В.А., Ашуралиева Н.Д., Холикова Д.С.Zhuraeva M.A., Aleynik V.A., Ashuralieva N.D., Kholikova D.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nogr.org/jour/article/view/1785

Регуляцию пищеварительных желез желудка и поджелудочной железы в организме животных и человека обеспечивают пептиды, большинство из которых пребывают в различных молекулярных формах. Установлено 10 молекулярных форм пептидов гастриновой группы и 5 пептидов холецистокининовой (ХЦК) группы, содержащих в своей структуре от 4 до 56 аминокислот, физиологическая роль которых мало изучена. Доказано, что печень выводит до 85% короткоцепочных пептидов гастриновой (пентагастрин) и холецистокининовой (ХЦК-8) групп.

The regulation of the digestive glands of the stomach and pancreas in the body of animals and humans is provided by peptides, most of which are in various molecular forms. 10 molecular forms of peptides of the gastrin group and 5 peptides of the cholecystokinin (CCK) group have been identified, containing in their structure from 4 to 56 amino acids, the physiological role of which has been little studied. It has been proven that the liver removes up to 85% of short-chain peptides of the gastrin (pentagastrin) and cholecystokinin (CCK-8) groups.

короткоцепочные пептидыхолецистокинингастринпеченьгастрин–17утилизацияshort-chain peptidescholecystokiningastrinlivergastrin-17utilizationReferencesAleynik V.A., Babich S. M. [The effect of various doses of trypsin on the change in liver utilization of pentagastrin]. Vestnik TMA – Bulletin of TMA, 2013, no. 1, pp. 13–16. (in Russ.)Aleynik V.A., Babich S. M. [The effect of various doses of trypsin on the change in liver utilization of pentagastrin]. Vestnik TMA – Bulletin of TMA, 2013, no. 1, pp. 13–16. (in Russ.)Aleynik V.A., Babich S. M. [The effect of pancreatic proteolytic and non-proteolytic hydrolases on the change in liver utilization of pentagastrin]. Jurnalteoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2013, no.5, pp.20–23. (in Russ.)Aleynik V.A., Babich S. M. [The effect of pancreatic proteolytic and non-proteolytic hydrolases on the change in liver utilization of pentagastrin]. Jurnalteoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2013, no.5, pp.20–23. (in Russ.)Aleynik V.A., Babich S. M. [Change in pancreatic secretion with the introduction of various doses of trypsin into the peripheral and portal veins]. Jurnalteoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2012, no.4, pp.9–12. (in Russ.)Aleynik V.A., Babich S. M. [Change in pancreatic secretion with the introduction of various doses of trypsin into the peripheral and portal veins]. Jurnalteoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2012, no.4, pp.9–12. (in Russ.)Babich S.M., Aleynik V. A. [Changes in gastric secretion when pentagastrin and leu-enkephalin are introduced into the peripheral and portal veins]. Journal of vrach-aspirant, Voronej – Journal Postgraduate Student, Voronezh, 2010, no. 5,2 (42), pp.252–257. (in Russ.)Babich S.M., Aleynik V. A. [Changes in gastric secretion when pentagastrin and leu-enkephalin are introduced into the peripheral and portal veins]. Journal of vrach-aspirant, Voronej – Journal Postgraduate Student, Voronezh, 2010, no. 5,2 (42), pp.252–257. (in Russ.)AndreevaYu.V. [The effect of fasting and resumption of feeding on the secretory function of the stomach. Candidate biol. Sci. diss.]. St. Petersburg, 2007, 140 p. (in Russ.)AndreevaYu.V. [The effect of fasting and resumption of feeding on the secretory function of the stomach. Candidate biol. Sci. diss.]. St. Petersburg, 2007, 140 p. (in Russ.)Smelisheva L. N. [Secretory function of the stomach and pancreas under the influence of emotional stress. Candidate med. sci. diss.]. Tyumen, 2007, 278 p. (in Russ.)Smelisheva L. N. [Secretory function of the stomach and pancreas under the influence of emotional stress. Candidate med. sci. diss.]. Tyumen, 2007, 278 p. (in Russ.)Akere A., et al. Upper gastrointestinal endoscopy in patients with cirrhosis: spectrum and prevalence of lesions. Annals of tropical medicine and public health, 2016, Vol. 9, No.2, 112 P. (in Russ.)Akere A., et al. Upper gastrointestinal endoscopy in patients with cirrhosis: spectrum and prevalence of lesions. Annals of tropical medicine and public health, 2016, Vol. 9, No.2, 112 P. (in Russ.)Bhattacharyya R., et al. A prospective pilot study of the prevalence of pancreatic disease in patients with alcohol related liver disease using faecal elastase-1. Gut, 2011, Vol.60, Suppl 1, С. A238-A238.Bhattacharyya R., et al. A prospective pilot study of the prevalence of pancreatic disease in patients with alcohol related liver disease using faecal elastase-1. Gut, 2011, Vol.60, Suppl 1, С. A238-A238.Hoffmaster K.A., Zamek-Gliszczynski M.J., Pollack G. M., Brouwer K. L. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems. J Pharmacol Exp Ther. 2004 Dec;311(3):1203–10. doi: 10.1124/jpet.104.070201.Hoffmaster K.A., Zamek-Gliszczynski M.J., Pollack G. M., Brouwer K. L. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems. J Pharmacol Exp Ther. 2004 Dec;311(3):1203–10. doi: 10.1124/jpet.104.070201.Kalaitzakis E, Bjornsson E Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition. World J Gastroenterol. 2008 Jun 7;14(21):3438–9. doi: 10.3748/wjg.14.3438.Kalaitzakis E, Bjornsson E Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition. World J Gastroenterol. 2008 Jun 7;14(21):3438–9. doi: 10.3748/wjg.14.3438.Katakura Y., Yotsuyanagi H., Hashizume K., et al. Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol. 2005 Jun 21;11(23):3508–13. doi: 10.3748/wjg.v11.i23.3508.Katakura Y., Yotsuyanagi H., Hashizume K., et al. Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol. 2005 Jun 21;11(23):3508–13. doi: 10.3748/wjg.v11.i23.3508.Mazaki-Tovi M., Segev G., Yas-Natan E., Lavy E. Serum gastrin concentrations in dogs with liver disorders. Vet Rec. 2012 Jul 7;171(1):19. doi: 10.1136/vr.100627.Mazaki-Tovi M., Segev G., Yas-Natan E., Lavy E. Serum gastrin concentrations in dogs with liver disorders. Vet Rec. 2012 Jul 7;171(1):19. doi: 10.1136/vr.100627.Ramachandran R., Hollenberg M. D. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1): S263–82. doi: 10.1038/sj.bjp.0707507.Ramachandran R., Hollenberg M. D. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1): S263–82. doi: 10.1038/sj.bjp.0707507.Rehfeld J.F., Bundgaard J. R., Hannibal J., et al. The Cell-Specific Pattern of Cholecystokinin Peptides in Endocrine Cells Versus Neurons Is Governed by the Expression of Prohormone Convertases 1/3, 2, and 5/6. Endocrinology. 2008 Apr;149(4):1600–8. doi: 10.1210/en.2007–0278.Rehfeld J.F., Bundgaard J. R., Hannibal J., et al. The Cell-Specific Pattern of Cholecystokinin Peptides in Endocrine Cells Versus Neurons Is Governed by the Expression of Prohormone Convertases 1/3, 2, and 5/6. Endocrinology. 2008 Apr;149(4):1600–8. doi: 10.1210/en.2007–0278.Valentini L., Schuetz T., Omar A., Gläser S., Kasim E., et al. Abnormal plasma peptide YY(3–36) levels in patients with liver cirrhosis. Nutrition. 2011 Sep;27(9):880–4. doi: 10.1016/j.nut.2010.12.013.Valentini L., Schuetz T., Omar A., Gläser S., Kasim E., et al. Abnormal plasma peptide YY(3–36) levels in patients with liver cirrhosis. Nutrition. 2011 Sep;27(9):880–4. doi: 10.1016/j.nut.2010.12.013.

The authors declare that there are no conflicts of interest present.